USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Clarius Mobile Health Corp.

USPTO PatentsView assignee record — 71 granted patents across 16 technology areas, active 2017–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

71
Total patents granted
16
CPC technology areas
16.8
Avg claims per patent
+510%
5-year filing velocity

The verdict

Clarius holds 71 US patents across 16 technology areas — rank #4,872 of 50,000 tracked assignees.

#4,872
of 50,000 US assignees by volume
Top 16%
by Innovation Score (48.7/100)
16.8
avg claims per patent
+510%
filing velocity, last 5 yrs

Portfolio overview

Clarius Mobile Health Corp. has been granted 71 US utility patents between 2017 and 2025, placing Clarius Mobile Health Corp. at rank #4,872 across all assignees tracked by PlainPatent. This portfolio spans 16 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.8 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, Clarius Mobile Health Corp. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 48.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 61 grants, compared with 10 in the 2015–2019 window — a +510% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Clarius Mobile Health Corp.'s 16.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 16 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Clarius Mobile Health Corp. against peers pursuing similar technology classes.

How does Clarius compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Clarius holds 71 patents — placing it at rank #4,872 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

Clarius's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

49 Top 16% higher than 84% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). This entry sits in this band. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

051015 201720182019202020212022202320242025 11
USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
Clarius Mobile Health Corp. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 2 2.8%
2018 4 5.6%
2019 4 5.6%
2020 11 15.5%
2021 7 9.9%
2022 11 15.5%
2023 12 16.9%
2024 9 12.7%
2025 11 15.5%

Which technologies does Clarius Mobile Health Corp. patent most?

Top 15 of 16 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Velocity Accelerating

Where it ranks

Overall rank by patents

#4,872

Across all tracked assignees

Innovation Score

48.7 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Clarius Mobile Health Corp. hold?
Clarius Mobile Health Corp. holds 71 US granted patents filed between 2017 and 2025, spanning 16 technology areas.
What is Clarius Mobile Health Corp.'s Innovation Score?
Clarius Mobile Health Corp. has an Innovation Score of 48.7 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Clarius Mobile Health Corp. focus on?
Clarius Mobile Health Corp.'s top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 57 patents. The company has filed patents in 16 CPC subclasses total.
Is Clarius Mobile Health Corp.'s patent filing rate increasing or decreasing?
Clarius Mobile Health Corp.'s recent filing velocity is +510% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Clarius Mobile Health Corp.'s patents?
Clarius Mobile Health Corp.'s patents average 16.8 claims each. This falls within the standard range, providing solid legal coverage.
How is the Clarius Mobile Health Corp. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

How to use this portfolio

Clarius's 71 grants land it in the top 16% by Innovation Score — but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance — Clarius ranks #4,872 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61B — see who else leads that technology area. A61B leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity — not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Data sources used on this page
  • USPTO PatentsView — the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) — the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search — the official interface to verify the status of any individual patent. ppubs.uspto.gov